查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010019

替代和补充医学市场：2026年至2032年全球市场预测，按治疗方法、疾病、最终用户和分销管道划分

Alternative & Complementary Medicine Market by Therapy Type, Disease Indication, End-User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，替代和补充医学市场价值将达到 1,554.4 亿美元，到 2026 年将成长到 1,751.9 亿美元，到 2032 年将达到 3,747.1 亿美元，复合年增长率为 13.39%。

主要市场统计数据
基准年 2025 1554.4亿美元
预计年份：2026年 1751.9亿美元
预测年份 2032 3747.1亿美元
复合年增长率 (%) 13.39%

全面概述整合医学和补充医学在现代医疗保健选择和相关人员主导的采纳途径中的定位。

如今，在临床医生、保险公司和知情消费者的日益认可下，替代和补充医学在全球医疗保健生态系统中占据着独特且快速发展的地位。患者对非药物和整体疗法的需求推动了人们对各种疗法的兴趣，从芳香疗法、植物疗法、营养补充剂、机能性食品和营养保健品等生物疗法，到针灸、能量疗法、磁疗和灵气疗法等能量疗法。同时，脊骨神经医学疗法和以身体为基础的疗法，如脊椎按摩疗法、拔罐疗法、按摩疗法、整骨疗法和反射疗法，继续吸引着自费患者和传统医疗保健机构转诊的患者；而催眠疗法、冥想和放鬆技巧等身心疗法也越来越多地被纳入慢性病护理路径。阿育吠陀、同类疗法、自然疗法和传统中医等传统替代医学体系在许多地区仍然根深蒂固，并透过调查计画和整合医学诊所获得机构认可。

数位接取、证据产生、监管清晰度和消费者主导的个人化是塑造综合医疗保健普及的变革力量。

由于结构性、技术性和文化性因素的共同作用，替代和补充医学的模式正在发生变化，这些因素正在重新定义实践模式和患者的期望。数位健康平台和远距健康服务透过提供远距身心介入和饮食、营养补充品和生活方式疗法的线上咨询，扩大了服务范围，同时也带来了新的品质保证需求。同时，对临床检验的日益重视推动了随机对照试验、系统性证据评估和真实世界证据（REW）计画的增加，这些都影响着药物的采纳决策和临床医生的转诊。

评估近期价格调整如何重组整个综合治疗产品线的供应链、采购决策和商业策略。

关税和贸易政策的变化会对整个替代和补充医学价值链产生即时和下游影响，尤其是在植物性成分、特殊成分和治疗医疗设备，迫使製造商和经销商重新评估筹资策略和库存缓衝。为此，一些公司正在加快供应商多元化，寻求替代原材料来源，并调整产品配方以减少对关税敏感型原材料的依赖。

基于细分市场的分析揭示了每种治疗方法类型、目标疾病、最终用户环境和分销管道的不同商业化逻辑。

透过分析需求推动要素、供应环境和通路经济效益，市场区隔得以提供切实可行的洞察。对治疗方法类型的分析表明，生物治疗方法拥有较高的消费者认知度和零售潜力，而营养补充剂和机能性食品疗法凭藉频繁的重复使用以及某些地区的保险覆盖保持着一定的韧性，而身心疗法则正透过数位平台和企业健康计划有效地扩展。传统替代医学体系保留文化信誉，并且通常与当地医疗保健机构合作，因此，采取具有文化敏感性的互动策略至关重要。

区域差异和策略重点受到全球主要区域法规结构、文化传统和供应链发展的影响。

区域趋势法律规范、文化接受度和供应链结构产生显着影响，从而为每个相关人员创造了不同的策略重点。美洲地区的市场环境以消费者主导的需求、创业型零售管道以及与临床环境日益融合为特征，尤其侧重于膳食补充剂、营养保健品和身心数位服务。支付和报销机制仍然复杂多样，因此商业策略需要经常在直接面向消费者和机构合作之间取得平衡。

一项结合临床检验、供应链管理和数位化参与的企业策略，旨在建立信任并扩大综合医疗保健服务的规模。

主要企业正透过整合临床检验、供应链韧性和数位互动等要素，建构差异化竞争优势。投资于严谨临床研究（包括随机对照试验和真实世界数据 (RWE) 收集）的企业，在与医疗机构建立合作关係和获得临床医生认可方面更具优势。另一些企业则致力于建立垂直整合的供应链，以管理植物来源成分和特殊萃取物的品质和可追溯性，从而降低贸易中断带来的风险，并提高产品一致性。

高阶主管面临的实际策略挑战，包括加快临床接受度、确保供应弹性以及扩展数位化驱动的护理路径。

行业领导者应采取多管齐下的方法，将证据生成、业务永续营运和客户参与相结合，从而将兴趣转化为可持续的采纳。首先，应优先进行旨在解答医疗专业人员和保险公司疑问的临床和真实世界证据项目，并儘早与学术伙伴合作，设计符合临床标准且便于在同行评审期刊上发表的研究。其次，应实现采购来源多元化，并投资于植物性成分和医疗设备原料的可追溯性系统，以降低关税和供应中断的风险，同时满足日益增长的永续性认证需求。

采用稳健的混合方法研究途径，结合与关键相关人员的访谈、系统性的证据审查和供应链分析以及检验查核点。

本报告的研究采用了一种多层次、混合方法的研究策略，旨在从多个相关人员的观点对证据进行三角验证。主要研究包括对临床医生、产品开发人员、供应链专家和支付方进行结构化检验，并辅以与辅助疗法领域的医疗保健专业人员的定性讨论。次要研究则涉及对同行评审的临床文献、监管指导文件、政策声明和行业报告进行系统性回顾，以整合安全性、有效性和合规性趋势的最新证据。

简洁的结论强调证据、营运韧性和协作整合，以实现补充疗法的潜力。

总而言之，在消费者对整体照护的需求、不断扩大的实证医学基础以及改善医疗服务可近性和监测的技术因素的推动下，替代和补充医学在更广泛的医疗保健体系中发挥着日益重要的作用。从生物製药到身心疗法和传统医学体系，各种疗法的相互作用正在形成多元化的商业化路径，这需要製定个人化的临床、监管和供应策略。关税和贸易趋势迫切需要增强供应链的韧性并实现采购来源多元化，而区域差异则凸显了采取文化敏感型方法的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按疗法类型分類的替代和补充医学市场

  • 生物疗法
    • 芳香疗法
    • 植物疗法
    • 营养补充品
    • 机能性食品及营养保健品
  • 能量疗法
    • 针刺
    • 疗癒之触
    • 磁疗
    • 灵气
  • 手法治疗和身体疗法
    • 脊骨神经医学疗法
    • 拔罐
    • 按摩疗法
    • 整骨疗法
    • 反射疗法
  • 心身医学
    • 催眠（催眠术）
    • 冥想
    • 放鬆方法
  • 传统替代医学体系
    • 阿育吠陀
    • 同类疗法
    • 自然疗法
    • 中药

第九章：替代和补充医学市场：按疾病适应症划分

  • 癌症支持和安宁疗护
  • 心血管健康
  • 糖尿病管理
  • 胃肠道问题
  • 失眠和睡眠障碍
  • 心理健康与忧郁症
  • 疼痛管理
  • 呼吸系统疾病
  • 皮肤/毛髮疾病
  • 压力和焦虑症

第十章：替代和补充医学市场：按最终用户划分

  • 学术和研究机构
  • 居家照护设施
  • 医院和专科诊所
  • 私人执业者
  • 健康中心及水疗中心

第十一章：替代和补充医学市场：按分销管道划分

  • 电子商务
  • 实体店面
    • 健康与保健零售店
    • 药局/药局

第十二章：替代和补充医学市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：替代与补充医学市场：按群体划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 替代及补充医学市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国替代与补充医学市场

第十六章：中国替代与补充医学市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AmeriCare Physical Therapy by Ivy Rehab
  • AYUSH Ayurvedic Pte Ltd.
  • Baidyanath Group
  • Boiron
  • Cipla Limited
  • Dabur India Ltd.
  • Dr. Willmar Schwabe India Pvt. Ltd.
  • Emami Limited
  • First Natural Brands Ltd.
  • Full Motion Physical Therapy
  • Herb Pharm, LLC
  • Mountain Rose Herbs
  • Nature's Bounty, Inc. by Nestle Health Science
  • Nelson & Co Ltd.
  • Nordic Naturals
  • PEKANA Naturheilmittel GmbH
  • Pharmesis International Ltd.
  • Rocky Mountain Oils LLC
  • schwa-medico GmbH
  • Seirin Corporation
  • Sheng Chang Pharmaceutical Company
  • The Arya Vaidya Pharmacy（CBE）Ltd.
  • The Healing Company, Inc.
  • The Himalaya Drug Company
  • Vicco Laboratories
  • Weleda AG
  • Wen Ken Group
Product Code: MRR-434CCDA04DB7

The Alternative & Complementary Medicine Market was valued at USD 155.44 billion in 2025 and is projected to grow to USD 175.19 billion in 2026, with a CAGR of 13.39%, reaching USD 374.71 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 155.44 billion
Estimated Year [2026] USD 175.19 billion
Forecast Year [2032] USD 374.71 billion
CAGR (%) 13.39%

A panoramic introduction that situates integrative and complementary therapies within contemporary healthcare choices and stakeholder-driven adoption pathways

Alternative and complementary medicine now occupies a distinct and rapidly evolving position within global health ecosystems, driven by a broadening acceptance among clinicians, payers, and informed consumers. Patient demand for non-pharmacologic and holistic approaches has expanded interest in therapies ranging from biologically based options such as aromatherapy, botanical medicine, dietary supplements, and functional food and nutraceuticals to energy therapies including acupuncture, healing touch, magnet therapy, and Reiki. At the same time, manipulative and body-based methods like chiropractic therapy, cupping, massage therapy, osteopathic manipulation, and reflexology continue to attract both self-pay consumers and referrals from conventional providers, while mind-body medicine practices such as hypnotherapy, meditation, and relaxation techniques are increasingly integrated into chronic care pathways. Traditional alternative medicine systems, including Ayurveda, homeopathy, naturopathy, and Traditional Chinese medicine, remain culturally embedded in many regions and are gaining institutional visibility through research programs and integrative clinics.

Transitional dynamics are critical: the interplay between greater clinical evidence generation, patient empowerment through digital tools, and evolving reimbursement attitudes is reshaping pathways to adoption. Consequently, stakeholders must navigate heterogenous regulatory environments, supply chain complexities for botanical and device inputs, and the need for robust safety and efficacy evidence. This report establishes a foundational view of these forces and prepares decision-makers to engage with the nuanced opportunities and operational realities of integrative health delivery.

Transformational forces shaping integrative healthcare adoption including digital access, evidence generation, regulatory clarity, and consumer-driven personalization

The landscape of alternative and complementary medicine is shifting under a confluence of structural, technological, and cultural forces that are redefining practice models and patient expectations. Digital health platforms and telewellness services are enabling remote access to mind-body interventions and virtual consultations for diet, nutraceuticals, and lifestyle therapies, increasing reach while creating new quality assurance demands. Concurrently, the rising emphasis on clinical validation has prompted more randomized trials, systematic evidence reviews, and real-world evidence initiatives, which influence formulary considerations and clinician referrals.

Regulatory trajectories are also in motion; agencies in multiple jurisdictions are clarifying pathways for safety, labeling, and claims, thereby influencing product development and marketing strategies. Moreover, consumer preferences are evolving toward personalized, preventive, and sustainability-oriented offerings, which drives interest in functional foods and botanicals sourced through traceable supply chains. As a result, integration models that blend conventional care with complementary modalities-such as hospital-based integrative clinics and academic research collaborations-are emerging as transformative delivery options. Taken together, these shifts are creating both opportunities for scale and new expectations around evidence, practitioner credentialing, and supply chain integrity that will determine which therapies move from niche to mainstream.

Assessment of how recent tariff adjustments have reshaped supply chains, sourcing decisions, and commercial strategies across integrative therapy product lines

Policy changes in tariffs and trade can have immediate and downstream effects across the alternative and complementary medicine value chain, particularly when supply of raw botanicals, specialty ingredients, and therapeutic devices is globally distributed. Recent tariff adjustments in the United States have heightened attention on import costs for botanical materials, concentrated extracts, and certain device classes, prompting manufacturers and distributors to reassess sourcing strategies and inventory buffers. In response, some firms have accelerated supplier diversification, sought alternative raw material origins, or altered product formulations to rely less on tariff-exposed inputs.

Beyond procurement, price pressures can influence distribution decisions and the economics of retail channels. E-commerce platforms, which have expanded consumer access to supplements, aromatherapy products, and home-use devices, may absorb some cost changes, while brick-and-mortar wellness centers and pharmacies reassess retail margins and stocking choices. Regulatory compliance costs and documentation requirements tied to imported materials can further compound operational complexity, encouraging forward-looking firms to invest in supplier due diligence and traceability systems. Additionally, tariff-driven shifts can catalyze nearshoring and regional manufacturing investments, with consequences for quality control, batch standardization, and clinical reproducibility. In short, trade policy changes are amplifying the need for strategic supply chain resilience, cost management, and clear communication with clinical partners and consumers about product provenance and quality.

Segment-driven analysis revealing distinct commercialization logics across therapy types, disease alignments, end-user settings, and distribution channels

Segmentation yields actionable insight when examined in relation to demand drivers, delivery settings, and channel economics. When therapies are parsed by type, biologically based therapies demonstrate strong consumer familiarity and retail viability, with dietary supplements and functional foods benefiting from lifestyle positioning and point-of-sale visibility. Energy therapies such as acupuncture and Reiki tend to rely on practitioner networks and clinic referrals, which underscores the importance of credentialing and training pipelines. Manipulative and body-based methods derive resilience from frequent repeat utilization and insurance adjudication in some jurisdictions, while mind-body practices scale effectively through digital platforms and institutional wellness programs. Traditional alternative medicine systems retain cultural credibility and often operate alongside community-based providers, necessitating culturally sensitive engagement strategies.

Evaluating the market through disease indications clarifies clinical alignment: therapies supporting cancer palliative care, mental health and depression, stress and anxiety, and pain management intersect strongly with multidisciplinary care teams and integrative pathways. End-user segmentation highlights different commercialization logics; academic and research institutes prioritize evidence generation and clinical validation, hospitals and specialty clinics focus on integration and referral workflows, wellness centers and spas emphasize consumer experience and branding, home care settings require easy-to-use products and remote support, and individual practitioners depend on professional supply channels and continuing education. Distribution channel segmentation reveals a growing e-commerce presence for directly shipped products and a continued role for offline retail, where health and wellness stores and pharmacies provide professional counters and guided purchase environments. Understanding the interactions among these segments enables tailored product development, targeted clinical evidence programs, and differentiated commercial models.

Regional differentiation and strategic priorities driven by regulatory frameworks, cultural traditions, and supply chain footprints across major global territories

Regional dynamics substantially influence regulatory frameworks, cultural acceptance, and supply chain configurations, producing differentiated strategic priorities for stakeholders. In the Americas, consumer-driven demand, entrepreneurial retail channels, and increasing integration into clinical settings characterize the environment, with particular emphasis on supplements, nutraceuticals, and mind-body digital offerings. Payment and reimbursement landscapes remain heterogeneous, so commercial strategies frequently balance direct-to-consumer engagement with institutional partnerships.

In Europe, Middle East & Africa, regulatory harmonization efforts and stringent safety standards shape product claims and labeling, while cultural practices in some markets support traditional medicine systems. This region also places strong emphasis on sustainability and traceability, prompting investment in certified sourcing and environmental stewardship. In the Asia-Pacific region, long-standing traditions in systems such as Ayurveda and Traditional Chinese medicine provide deep practitioner networks and localized supply chains, and local manufacturing capacity for botanicals and devices creates sourcing advantages. Meanwhile, rapid digital adoption in several Asia-Pacific markets accelerates telehealth and e-commerce distribution for both services and consumer products. Navigating these regional contrasts requires adaptive regulatory strategies, culturally informed marketing, and targeted investments in local supply and clinical partnerships to ensure both compliance and market relevance.

Corporate strategies that combine clinical validation, supply chain control, and digital engagement to build trust and scale in integrative healthcare offerings

Leading organizations are differentiating through portfolios that blend clinical validation, supply chain resilience, and digital engagement. Firms investing in rigorous clinical research, including randomized trials and real-world evidence collection, are better positioned to secure institutional partnerships and clinician endorsements. Others are pursuing vertically integrated supply chains to control quality and traceability for botanicals and specialty extracts, thereby reducing vulnerability to trade disruptions and enhancing product consistency.

Strategic collaborations between product manufacturers, service providers, and academic centers are emerging as an efficient pathway to scale evidence-informed offerings. Meanwhile, companies building robust digital ecosystems-encompassing telewellness platforms, patient education content, and adherence support-are creating stickier customer relationships and opening subscription-based revenue opportunities. Some players are also prioritizing sustainability credentials and ethical sourcing as differentiators in consumer-facing branding. Across the competitive landscape, there is a clear premium on adaptability: organizations that combine scientific credibility, operational rigor, and nimble commercial models are most likely to capture institutional trust and consumer loyalty in a field that demands both safety and cultural competence.

Practical strategic imperatives for executives to accelerate clinical acceptance, ensure supply resilience, and scale digitally enabled care pathways

Industry leaders should adopt a multi-pronged approach that aligns evidence generation, operational resilience, and customer engagement to convert interest into sustainable adoption. First, prioritize clinical and real-world evidence initiatives that are designed to answer practitioner and payer questions; engage academic partners early to design studies that meet clinical standards and facilitate peer-reviewed dissemination. Second, diversify sourcing and invest in traceability systems for botanical and device inputs to mitigate tariff and supply disruption risks while meeting growing demand for sustainability credentials.

Third, develop integrated digital platforms that support remote delivery of mind-body interventions, enable practitioner networks, and provide adherence and outcome tracking to strengthen value propositions for institutional buyers. Fourth, tailor go-to-market models to end-user needs: create institutional bundles for hospitals and clinics, experience-led offerings for wellness centers, and simplified, education-rich formats for home care. Fifth, proactively engage with regulators and standards bodies to shape pragmatic compliance pathways and reduce time-to-adoption for novel products. Finally, cultivate cross-sector partnerships that align product innovation with clinical pathways and payer priorities to accelerate integration and reimbursement conversations. By executing these actions with clear milestones and measurable KPIs, leaders can convert emergent trends into durable competitive advantage.

Robust mixed-methods research approach combining primary stakeholder interviews, systematic evidence review, and supply chain analysis with validation checkpoints

The research underpinning this report used a layered, mixed-methods approach designed to triangulate evidence from multiple stakeholder perspectives. Primary research included structured interviews with clinicians, product developers, supply chain specialists, and payers, complemented by qualitative discussions with practitioners across complementary modalities. Secondary research encompassed a systematic review of peer-reviewed clinical literature, regulatory guidance documents, policy statements, and industry reporting to synthesize current evidence on safety, efficacy, and compliance trends.

Quantitative inputs were drawn from aggregated consumption patterns, facility adoption indicators, and distribution channel performance signals, with careful attention to data provenance and methodological transparency. Supply chain mapping combined import-export flows, supplier network analysis, and tariff exposure assessment to identify vulnerabilities and adaptive responses. All findings were validated through expert advisory review and cross-checked for consistency, with limitations duly noted where evidence gaps exist. The methodology emphasizes reproducibility, and appendices provide detailed protocols, interview guides, and criteria for study inclusion to aid further inquiry or custom replication.

Concise concluding synthesis emphasizing evidence, operational resilience, and collaborative integration to realize the potential of complementary therapies

In summary, alternative and complementary medicine occupies an increasingly influential role within broader healthcare systems, driven by consumer demand for holistic care, an expanding evidence base, and technological enablers that improve access and monitoring. The interplay of therapy types-from biologically based products to mind-body practices and traditional systems-creates diverse commercialization pathways that require tailored clinical, regulatory, and supply strategies. Tariff and trade developments have added urgency to supply chain resilience and sourcing diversification, while regional differences underscore the need for culturally attuned approaches.

For decision-makers, the imperative is clear: combine rigorous evidence generation with operational excellence and digitally enabled service delivery to capture growth opportunities and mitigate risk. Organizations that invest in credible clinical research, transparent sourcing, and practitioner education will be best positioned to integrate complementary therapies into mainstream care in a manner that is safe, effective, and sustainable. Moving forward, collaborative models that bridge industry, academia, and clinical practice will be central to converting interest into enduring adoption and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Alternative & Complementary Medicine Market, by Therapy Type

  • 8.1. Biologically Based Therapies
    • 8.1.1. Aromatherapy
    • 8.1.2. Botanical Medicine
    • 8.1.3. Dietary Supplements
    • 8.1.4. Functional Food & Nutraceuticals
  • 8.2. Energy therapies
    • 8.2.1. Acupuncture
    • 8.2.2. Healing touch
    • 8.2.3. Magnet therapy
    • 8.2.4. Reiki
  • 8.3. Manipulative & Body-Based Methods
    • 8.3.1. Chiropractic Therapy
    • 8.3.2. Cupping
    • 8.3.3. Massage Therapy
    • 8.3.4. Osteopathic Manipulation
    • 8.3.5. Reflexology
  • 8.4. Mind-Body Medicine
    • 8.4.1. Hypnotherapy (hypnosis)
    • 8.4.2. Meditation
    • 8.4.3. Relaxation Techniques
  • 8.5. Traditional Alternative Medicine Systems
    • 8.5.1. Ayurveda
    • 8.5.2. Homeopathy
    • 8.5.3. Naturopathy
    • 8.5.4. Traditional Chinese medicine

9. Alternative & Complementary Medicine Market, by Disease Indication

  • 9.1. Cancer Support & Palliative Care
  • 9.2. Cardiovascular Health
  • 9.3. Diabetes Management
  • 9.4. Gastrointestinal Issues
  • 9.5. Insomnia & Sleep Disorders
  • 9.6. Mental Health & Depression
  • 9.7. Pain Management
  • 9.8. Respiratory Disorders
  • 9.9. Skin & Hair Disorders
  • 9.10. Stress & Anxiety Disorders

10. Alternative & Complementary Medicine Market, by End-User

  • 10.1. Academic & Research Institutes
  • 10.2. Home Care Settings
  • 10.3. Hospitals & Specialty Clinics
  • 10.4. Individual Practitioners
  • 10.5. Wellness Centers & Spas

11. Alternative & Complementary Medicine Market, by Distribution Channel

  • 11.1. E-commerce
  • 11.2. Offline Retail
    • 11.2.1. Health & Wellness Retail Stores
    • 11.2.2. Pharmacies & Drug Stores

12. Alternative & Complementary Medicine Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Alternative & Complementary Medicine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Alternative & Complementary Medicine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Alternative & Complementary Medicine Market

16. China Alternative & Complementary Medicine Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AmeriCare Physical Therapy by Ivy Rehab
  • 17.6. AYUSH Ayurvedic Pte Ltd.
  • 17.7. Baidyanath Group
  • 17.8. Boiron
  • 17.9. Cipla Limited
  • 17.10. Dabur India Ltd.
  • 17.11. Dr. Willmar Schwabe India Pvt. Ltd.
  • 17.12. Emami Limited
  • 17.13. First Natural Brands Ltd.
  • 17.14. Full Motion Physical Therapy
  • 17.15. Herb Pharm, LLC
  • 17.16. Mountain Rose Herbs
  • 17.17. Nature's Bounty, Inc. by Nestle Health Science
  • 17.18. Nelson & Co Ltd.
  • 17.19. Nordic Naturals
  • 17.20. PEKANA Naturheilmittel GmbH
  • 17.21. Pharmesis International Ltd.
  • 17.22. Rocky Mountain Oils LLC
  • 17.23. schwa-medico GmbH
  • 17.24. Seirin Corporation
  • 17.25. Sheng Chang Pharmaceutical Company
  • 17.26. The Arya Vaidya Pharmacy (CBE) Ltd.
  • 17.27. The Healing Company, Inc.
  • 17.28. The Himalaya Drug Company
  • 17.29. Vicco Laboratories
  • 17.30. Weleda AG
  • 17.31. Wen Ken Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY AROMATHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY AROMATHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY AROMATHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BOTANICAL MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BOTANICAL MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BOTANICAL MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY FUNCTIONAL FOOD & NUTRACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY FUNCTIONAL FOOD & NUTRACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY FUNCTIONAL FOOD & NUTRACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ACUPUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ACUPUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HEALING TOUCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HEALING TOUCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HEALING TOUCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MAGNET THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MAGNET THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MAGNET THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REIKI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REIKI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REIKI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CHIROPRACTIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CHIROPRACTIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CHIROPRACTIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CUPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CUPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CUPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MASSAGE THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MASSAGE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MASSAGE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OSTEOPATHIC MANIPULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OSTEOPATHIC MANIPULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OSTEOPATHIC MANIPULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REFLEXOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REFLEXOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REFLEXOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HYPNOTHERAPY (HYPNOSIS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HYPNOTHERAPY (HYPNOSIS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HYPNOTHERAPY (HYPNOSIS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MEDITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MEDITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MEDITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY RELAXATION TECHNIQUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY RELAXATION TECHNIQUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY RELAXATION TECHNIQUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY AYURVEDA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY AYURVEDA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY AYURVEDA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOMEOPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOMEOPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOMEOPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY NATUROPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY NATUROPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY NATUROPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL CHINESE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL CHINESE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL CHINESE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CANCER SUPPORT & PALLIATIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CANCER SUPPORT & PALLIATIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CANCER SUPPORT & PALLIATIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GASTROINTESTINAL ISSUES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GASTROINTESTINAL ISSUES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GASTROINTESTINAL ISSUES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY INSOMNIA & SLEEP DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY INSOMNIA & SLEEP DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY INSOMNIA & SLEEP DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MENTAL HEALTH & DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MENTAL HEALTH & DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MENTAL HEALTH & DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY SKIN & HAIR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY SKIN & HAIR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY SKIN & HAIR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY STRESS & ANXIETY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY STRESS & ANXIETY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY STRESS & ANXIETY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOSPITALS & SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOSPITALS & SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY INDIVIDUAL PRACTITIONERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY INDIVIDUAL PRACTITIONERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY INDIVIDUAL PRACTITIONERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY WELLNESS CENTERS & SPAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY WELLNESS CENTERS & SPAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY WELLNESS CENTERS & SPAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HEALTH & WELLNESS RETAIL STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HEALTH & WELLNESS RETAIL STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY HEALTH & WELLNESS RETAIL STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY PHARMACIES & DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY PHARMACIES & DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 248. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 250. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 251. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 254. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 255. GCC ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY OFFLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY BIOLOGICALLY BASED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY ENERGY THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MANIPULATIVE & BODY-BASED METHODS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY MIND-BODY MEDICINE, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY TRADITIONAL ALTERNATIVE MEDICINE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION ALTERNATIVE & COMPLEMENTARY MEDICINE MARKET